An access to Roche’s R&D
For 125 years, Roche has evolved medicine through pioneering innovation for the benefit of patients. With its unique R&D ecosystem, supported by the Institut Roche, Roche is a global healthcare leader, providing patients with life-changing solutions.
Roche’s success in figures, past and present
Throughout its history, the Roche Group has received many awards testifying to its scientific excellence:
43
Prix Galiensince 1970
38
Breakthrough Therapy Designationsfrom the FDA between 2013 and 2022
4
PRIME designationsfrom the European Union
Roche is the world’s leading investor in healthcare Research & Development:
14.8
Billions Swiss francsof budget for R&D in 2021
21.8%
PRIME designationsof turnover invested in R&D
0
No biosimilarssince 1970
80
exceptional therapeutic solutionsin the pipeline
Frédéric de Sauvage
Frédéric de Sauvage, VP Research Molecular Oncology , speaks about the challenges of the molecular oncology research at Genentech
Andrew Chan
Andrew Chan, SVP in Research Biology, answers 3 questions about how Big Data approach impacts gene identification and analysis in biomedical research
The Roche ecosystem:
fostering R&D for groundbreaking innovation
At the heart of the Roche R&D, the Institut Roche streamlines innovation by connecting and supporting all the Roche autonomous and synergic poles. Together, those divisions build an ecosystem of outstanding expertise, connecting with hundreds of external partners.